Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Unknown × Hyperaldosteronism × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Completed 3 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 443 Neoplasms 324 Colorectal Neoplasms 208 Prostatic Neoplasms 206 Lung Neoplasms 169 Carcinoma, Hepatocellular 148 Stomach Neoplasms 140 Pancreatic Neoplasms 131 Rectal Neoplasms 115 Motor Activity 103 Colonic Neoplasms 102 Carcinoma, Non-Small-Cell Lung 101 Uterine Cervical Neoplasms 98 Head and Neck Neoplasms 84 Polycystic Ovary Syndrome 77 Esophageal Neoplasms 73 Liver Neoplasms 60 Neoplasm Metastasis 59 Brain Neoplasms 59 Ovarian Neoplasms 54 Urinary Bladder Neoplasms 52 Recurrence 51 Fatigue 47 Pain 45 Endometrial Neoplasms 45 Melanoma 44 Thyroid Neoplasms 39 Lymphoma 39 Anxiety Disorders 38 Pain, Postoperative 35

Interventions

Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02030587 2017-04-25

LARFA

Chinese University of Hong Kong

Phase NA Unknown

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡